PDAC - Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying PDAC - Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

33 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

PDAC - Pancreatic Ductal Adenocarcinoma trial results

Completed

NCT06947382

Conditions: Cancer Diagnosis, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: HonorHealth Clinical Research Institute Scottsdale, Arizona, United States

St. John's Cancer Institute Burbank, California, United States

University of California San Diego La Jolla, California, United States

Stanford Gastroenterology and Hepatology Stanford, California, United States

View all 15 locations

Active, Not Recruiting

NCT06625320

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Mayo Clinic Cancer Center - Phoenix Phoenix, Arizona, United States

City of Hope-Duarte Duarte, California, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

View all 60 locations

Active, Not Recruiting

NCT05642962

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +18 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States